Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-09

FDA Approved: RASAGILINE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved Rising Pharma Holdings, Inc.'s rasagiline mesylate under an original application (ANDA 218163). This marks the approval of a generic rasagiline…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RASAGILINE (rasagiline)

Snippet

ORIG AP for RASAGILINE (RASAGILINE MESYLATE)